In men at risk of HIV infection, IgM, IgG1, IgG3, and IgA reach the human foreskin epidermis

Mucosal Immunology

Volumn 9, Issue 3, 2016, Pages 798-808

  Lemos, M P ^a   Karuna, S T ^a   Mize, G J ^a   Fong, Y ^a   Montano, S M ^b   Ganoza, C ^c   Lama, J R ^c   Sanchez, J ^c   McElrath, M J ^a,d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b Peru   (Peru)

^c ASOCIACIÓN CIVIL IMPACTA SALUD Y EDUCACIÓN   (Peru)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; TATA BINDING PROTEIN; IMMUNOGLOBULIN G;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL COUNT; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; EPIDERMIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFECTION RISK; MALE; OVARY FOLLICLE CELL; PREPUCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ADENOVIRIDAE; ADULT; CELL CULTURE; COLON; COMPARATIVE STUDY; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; METABOLISM; SERODIAGNOSIS;

ADENOVIRIDAE; ADULT; CELLS, CULTURED; COLON; EPIDERMIS; FORESKIN; GENE EXPRESSION PROFILING; HIV INFECTIONS; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; NEUTRALIZATION TESTS;

EID: 84964939413     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2015.103     Document Type: Article

References (53)

1. Lynch, R. M., Yamamoto, T. & McDermott, A. B. HIV vaccine research and discovery in the nonhuman primates model: A unified theory in acquisition prevention and control of SIV infection. Curr. Opin. HIV AIDS 8, 288-294 (2013).
2. Rerks-Ngarm, S. et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361, 2209-2220 (2009).
3. Haynes, B. F. et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 366, 1275-1286 (2012).
4. Yates, N. L. et al. Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination. Sci. Transl. Med. 6, 228ra239 (2014).
5. Chung, A. W. et al. Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines. Sci. Transl. Med. 6, 228ra238 (2014).
6. Goedert, J. J. et al. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet 2, 711-716 (1984).
7. Johnson, A. M. et al. Transmission of HIV to heterosexual partners of infected men and women. AIDS 3, 367-372 (1989).
8. Mestecky, J. Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites. J. Reprod. Immunol. 73, 86-97 (2007).
9. Auvert, B. et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 Trial. PLoS Med. 2, e298 (2005).
10. Gray, R. H. et al. Male circumcision for HIV prevention in men in Rakai, Uganda: A randomised trial. Lancet 369, 657-666 (2007).
11. Bailey, R. C. et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. Lancet 369, 643-656 (2007).
12. Sanchez, J. et al. Male circumcision and risk of HIV acquisition among MSM. AIDS 25, 519-523 (2011).
13. Goodreau, S. M. et al. What drives the US and Peruvian HIV epidemics in men who have sex with men (MSM)? PLoS One 7, e50522 (2012).
14. Dinh, M. H. et al. Visualization of HIV-1 interactions with penile and foreskin epithelia: clues for female-to-male HIV transmission. PLoS Pathog. 11, e1004729 (2015).
15. UNAIDS, W. A. New Data on Male Circumcision and HIV Prevention: Research Implications for Policy and Programming. WHO and UNAIDS, Montreux, Switzerland (2007).
16. Auvert, B. et al. Estimating the resources needed and savings anticipated from roll-out of adult male circumcision inSub-Saharan Africa. PLoS One3, e2679 (2008).
17. Hallett, T. B. et al. Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS One 3, e2212 (2008).
18. Herman-Roloff, A., Otieno, N., Agot, K., Ndinya-Achola, J. & Bailey, R. C. Acceptability of medical male circumcision among uncircumcised men in Kenya one year after the launch of the nationalmale circumcision program. PLoS One 6, e19814 (2011).
19. Tauber, P. F., Zaneveld, L. J., Propping, D. & Schumacher, G. F. Components of human split ejaculates. I. Spermatozoa, fructose, immunoglobulins, albumin, lactoferrin, transferrin and other plasma proteins. J. Reprod. Fertil. 43, 249-267 (1975).
20. Rumke, P. The origin of immunoglobulins in semen. Clin. Exp. Immunol. 17, 287-297 (1974).
21. Gelzayd, E. A., Kraft, S. C. & Kirsner, J. B. Distribution of immunoglobulins in human rectal mucosa. I. Normal control subjects. Gastroenterology 54, 334-340 (1968).
22. Macpherson, A. J., McCoy, K. D., Johansen, F. E. & Brandtzaeg, P. The immune geography of IgA induction and function. Mucosal Immunol. 1, 11-22 (2008).
23. Brandtzaeg, P., Baklien, K., Fausa, O. & Hoel, P. S. Immunohistochemical characterization of local immunoglobulin formation in ulcerative colitis. Gastroenterology 66, 1123-1136 (1974).
24. Crago, S. S. et al. Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. J. Immunol. 132, 16-18 (1984).
25. Kutteh,W. H., Prince, S. J., Hammond, K. R., Kutteh, C. C. & Mestecky, J. Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation. Clin. Exp. Immunol. 104, 538-542 (1996).
26. Moldoveanu, Z., Huang, W. Q., Kulhavy, R., Pate, M. S. & Mestecky, J. Human male genital tract secretions: both mucosal and systemic immune compartments contribute to the humoral immunity. J. Immunol. 175, 4127-4136 (2005).
27. Pudney, J. & Anderson, D. J. Immunobiology of the human penile urethra. Am. J. Pathol. 147, 155-165 (1995).
28. Bjercke, S. & Brandtzaeg, P. Glandular distribution of immunoglobulins, J chain, secretory component, and HLA-DR in the human endometrium throughout the menstrual cycle. Hum. Reprod. 8, 1420-1425 (1993).
29. Kutteh, W. H., Hatch, K. D., Blackwell, R. E. & Mestecky, J. Secretory immune system of the female reproductive tract: I. Immunoglobulin and secretory component-containing cells. Obstet. Gynecol. 71, 56-60 (1988).
30. Bruhns, P. et al. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 113, 3716-3725 (2009).
31. Kantele, A. et al. Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans. Infect. Immun. 66, 5630-5635 (1998).
32. Lubeck, M. D. et al. Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Res. Hum. Retroviruses 10, 1443-1449 (1994).
33. Yang, O. O. et al. Differential blood and mucosal immune responses against an HIV-1 vaccine administered via inguinal or deltoid injection. PLoS One 9, e88621 (2014).
34. Kutteh,W. H. & Mestecky, J. Secretory immunity in the female reproductive tract. Am. J. Reprod. Immunol. 31, 40-46 (1994).
35. Mehandru, S. et al. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J. Virol. 81, 599-612 (2007).
36. Hel, Z., McGhee, J. R. & Mestecky, J. HIV infection: first battle decides the war. Trends Immunol. 27, 274-281 (2006).
37. Li, Q. et al. Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science 323, 1726-1729 (2009).
38. Hladik, F. et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26, 257-270 (2007).
39. Hirbod, T. et al. HIV acquisition is associated with increased antimicrobial peptides and reduced HIV neutralizing IgA in the foreskin prepuce of uncircumcised men. PLoS Pathog. 10, e1004416 (2014).
40. Prodger, J. L. et al. Immune correlates of HIV exposure without infection in foreskins of men from Rakai, Uganda. Mucosal Immunol. 7, 634-644 (2014).
41. Curlin, M. E. et al. Frequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with men. PLoS One 5, e11321 (2010).
42. Buchbinder, S. P. et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): A double-blind, randomised, placebocontrolled, test-of-concept trial. Lancet 372, 1881-1893 (2008).
43. Kaetzel, C. S., Robinson, J. K., Chintalacharuvu, K. R., Vaerman, J. P. & Lamm, M. E. The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: A local defense function for IgA. Proc. Natl Acad. Sci. USA 88, 8796-8800 (1991).
44. Natvig, I. B., Johansen, F. E., Nordeng, T.W., Haraldsen, G. & Brandtzaeg, P. Mechanism for enhanced external transfer of dimeric IgA over pentameric IgM: studies of diffusion, binding to the human polymeric Ig receptor, and epithelial transcytosis. J. Immunol. 159, 4330-4340 (1997).
45. Gupta, S. et al. The neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells. PLoS Pathog. 9, e1003776 (2013).
46. Rothaeusler, K. et al. Antiviral antibodies and T cells are present in the foreskin of simian immunodeficiency virus-infected rhesus macaques. J. Virol. 86, 7098-7106 (2012).
47. Price, L.B. et al. The effects of circumcision on the penis microbiome. PLoS One 5, e8422 (2010).
48. Lemos, M. P. et al. The inner foreskin of healthy males at risk of HIV infection harbors epithelial CD4+ CCR5+ cells and has features of an inflamed epidermal barrier. PLoS One 9, e108954 (2014).
49. Hendrix, S. W. et al. Optimization of the skin multiple analyte profile bioanalytical method for determination of skin biomarkers from D-Squame tape samples. Skin Res. Technol. 13, 330-342 (2007).
50. Fong, Y., Sebestyen, K., Yu, X., Gilbert, P. & Self, S. nCal: A R package for nonlinear calibration. Bioinformatics 29, 2653-2654 (2013).
51. Rothschild, M. A., Bauman, A., Yalow, R. S. & Berson, S. A. Tissue distribution of I131 labeled human serum albumin following intravenous administration. J. Clin. Invest. 34, 1354-1358 (1955).
52. Aste-Amezaga, M. et al. Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines. Hum. Gene Ther. 15, 293-304 (2004).
53. Hollander, M., Wolfe, D. A. & Chicken, E. Nonparametric Statistical Methods, 3rd edn. (Wiley, Hoboken, NJ, 2013).